{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:05:54Z","timestamp":1768280754245,"version":"3.49.0"},"reference-count":44,"publisher":"Informa UK Limited","issue":"13","license":[{"start":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T00:00:00Z","timestamp":1460937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2016,7,31]]},"DOI":"10.2217\/fon-2016-0130","type":"journal-article","created":{"date-parts":[[2016,4,18]],"date-time":"2016-04-18T16:29:36Z","timestamp":1460996976000},"page":"1553-1563","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":87,"title":["ROBUST: Lenalidomide-R-Chop Versus Placebo-R-Chop in Previously Untreated Abc-Type Diffuse Large B-Cell Lymphoma"],"prefix":"10.1080","volume":"12","author":[{"given":"Grzegorz S","family":"Nowakowski","sequence":"first","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN55902, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Chiappella","sequence":"additional","affiliation":[{"name":"Division of Hematology, Citt\u00e0 della Salute e della Scienza Hospital & University, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E","family":"Witzig","sequence":"additional","affiliation":[{"name":"Division of Hematology, Mayo Clinic, Rochester, MN55902, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Spina","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, National Cancer Institute, Aviano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy D","family":"Gascoyne","sequence":"additional","affiliation":[{"name":"Department of Pathology & Lymphoid Cancer Research, BC Cancer Agency & BC Cancer Research Centre, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Celgene Corporation, Summit, NJ07901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyne","family":"Flament","sequence":"additional","affiliation":[{"name":"Celgene Corporation, Summit, NJ07901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Repici","sequence":"additional","affiliation":[{"name":"Celgene Corporation, Summit, NJ07901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Vitolo","sequence":"additional","affiliation":[{"name":"Division of Hematology, Citt\u00e0 della Salute e della Scienza Hospital & University, Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,4,18]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2015.01.001"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2008.07.002"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu109"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The non-Hodgkin\u2019s lymphoma classification project. Blood 89(11) 3909\u20133918 (1997).","DOI":"10.1182\/blood.V89.11.3909"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.4.1157.1157"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01467.x"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N. Engl. J. Med. 329(14) 987\u2013994 (1993).","DOI":"10.1056\/NEJM199309303291402"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-038257"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-524108"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.423"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012914"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2015.01.005"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.8280"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-322362"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-536433"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802885"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.60.2383"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb1503104"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5363"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.119"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4405"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21468"},{"key":"e_1_3_2_28_1","unstructured":"REVLIMID\u00ae (lenalidomide) prescribing information. Summit NJ USA Celgene Corporation (2015)."},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12172"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.3429"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq626"},{"issue":"2","key":"e_1_3_2_32_1","first-page":"239","article-title":"Lenalidomide monotherapy is clinically active in patients with relapsed\/refractory diffuse large B-cell lymphoma (DLBCL): a pooled analysis of data from 2 Phase II studies (NHL-002\/003)","volume":"95","author":"Czuczman MS","year":"2010","unstructured":"Czuczman MS , VoseJ, ZinzaniPLet al. Lenalidomide monotherapy is clinically active in patients with relapsed\/refractory diffuse large B-cell lymphoma (DLBCL): a pooled analysis of data from 2 Phase II studies (NHL-002\/003). Haematologica95(Suppl. 2), 239, Abstract 0574 (2010).","journal-title":"Haematologica"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26135"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.628.628"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.5714"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70191-3"},{"issue":"7","key":"e_1_3_2_37_1","first-page":"10705","article-title":"Lenalidomide alone or in combination with chemotherapy treatment for subtypes of diffuse large B cell lymphoma: a systematic review and meta-analysis","volume":"8","author":"Fang C","year":"2015","unstructured":"Fang C , ZhuD, DongHet al. Lenalidomide alone or in combination with chemotherapy treatment for subtypes of diffuse large B cell lymphoma: a systematic review and meta-analysis. Int. J. Clin. Exp. Med.8(7), 10705\u201310713 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200725050-00002"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.762977"},{"issue":"15","key":"e_1_3_2_40_1","article-title":"Development of the molecular diagnostic (MDX) DLBCL lymphoma subtyping test (LST) on the Ncounter analysis system","volume":"33","author":"Wallden B","year":"2015","unstructured":"Wallden B , FerreeS, RaviHet al. Development of the molecular diagnostic (MDX) DLBCL lymphoma subtyping test (LST) on the Ncounter analysis system. J. Clin. Oncol.33(Suppl. 15), Abstract 8536 (2015).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.1481.1481"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2435-6"},{"key":"e_1_3_2_44_1","unstructured":"ClinicalTrials.gov\n. www.clinicaltrials.gov\/ct2\/show\/NCT02285062."},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.131"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.9277"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2016-0130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:43:17Z","timestamp":1719124997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2016-0130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,18]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,7,31]]}},"alternative-id":["10.2217\/fon-2016-0130"],"URL":"https:\/\/doi.org\/10.2217\/fon-2016-0130","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}